Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)
CNY 22.22
(0.63%)
CNY 22.22
(0.63%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -755.56 Million CNY | 7.67% |
| 2022 | -818.3 Million CNY | -43.21% |
| 2021 | -571.42 Million CNY | -18.77% |
| 2020 | -481.12 Million CNY | -145.94% |
| 2019 | -195.62 Million CNY | -55.23% |
| 2018 | -126.02 Million CNY | -41.3% |
| 2017 | -89.19 Million CNY | -175.38% |
| 2016 | 118.32 Million CNY | -20.78% |
| 2015 | 149.36 Million CNY | 136.7% |
| 2014 | 63.1 Million CNY | 378.84% |
| 2013 | -22.62 Million CNY | -1326.65% |
| 2012 | 1.84 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -463.15 Million CNY | 45.49% |
| 2024 Q3 | -307.88 Million CNY | 39.62% |
| 2024 Q1 | -849.73 Million CNY | -12.46% |
| 2023 Q2 | -963.18 Million CNY | -14.37% |
| 2023 Q1 | -842.2 Million CNY | -2.92% |
| 2023 FY | -755.56 Million CNY | 7.67% |
| 2023 Q4 | -755.56 Million CNY | -5.34% |
| 2023 Q3 | -717.25 Million CNY | 25.53% |
| 2022 Q1 | -600.35 Million CNY | -5.06% |
| 2022 FY | -818.3 Million CNY | -43.21% |
| 2022 Q4 | -818.3 Million CNY | -21.04% |
| 2022 Q3 | -676.06 Million CNY | 2.59% |
| 2022 Q2 | -694.04 Million CNY | -15.61% |
| 2021 Q4 | -571.42 Million CNY | -22.62% |
| 2021 Q2 | -579.34 Million CNY | -13.36% |
| 2021 Q3 | -466 Million CNY | 19.56% |
| 2021 Q1 | -511.06 Million CNY | -6.22% |
| 2021 FY | -571.42 Million CNY | -18.77% |
| 2020 Q4 | -481.12 Million CNY | -25.96% |
| 2020 Q1 | -226.19 Million CNY | -15.63% |
| 2020 Q2 | -259.74 Million CNY | -14.83% |
| 2020 FY | -481.12 Million CNY | -145.94% |
| 2020 Q3 | -381.96 Million CNY | -47.06% |
| 2019 Q1 | -192.35 Million CNY | -52.63% |
| 2019 Q2 | -260.35 Million CNY | -35.35% |
| 2019 Q3 | -249.51 Million CNY | 4.16% |
| 2019 FY | -195.62 Million CNY | -55.23% |
| 2019 Q4 | -195.62 Million CNY | 21.6% |
| 2018 Q2 | -74.24 Million CNY | 58.43% |
| 2018 FY | -126.02 Million CNY | -41.3% |
| 2018 Q4 | -126.02 Million CNY | -672.02% |
| 2018 Q1 | -178.6 Million CNY | -100.25% |
| 2018 Q3 | -16.32 Million CNY | 78.01% |
| 2017 Q2 | -61.95 Million CNY | -162.42% |
| 2017 Q3 | -66.57 Million CNY | -7.47% |
| 2017 Q4 | -89.19 Million CNY | -33.96% |
| 2017 FY | -89.19 Million CNY | -175.38% |
| 2017 Q1 | 99.24 Million CNY | -16.12% |
| 2016 Q4 | 118.32 Million CNY | 0.0% |
| 2016 Q2 | 142.37 Million CNY | 322.01% |
| 2016 Q1 | 33.73 Million CNY | 0.0% |
| 2016 FY | 118.32 Million CNY | -20.78% |
| 2015 FY | 149.36 Million CNY | 136.7% |
| 2014 FY | 63.1 Million CNY | 378.84% |
| 2013 FY | -22.62 Million CNY | -1326.65% |
| 2012 FY | 1.84 Million CNY | 0.0% |